New drug tested for hereditary breast and ovarian cancers
Links shared publicly online about this topic.
- 66total visits
New drug tested for hereditary breast and ovarian cancers
View full resource at medicalxpress.com
Tags: Cancer, Ovarian Cancer, Drug, Women's Health, Medical
Most Recently Shared on August 17, 2011 at 3:32 pm By:
New drug tested for hereditary breast and ovarian cancers http://t.co/66ohTaQ
Also Shared By:
Health News - UK scientists trial new drug for hereditary breast and ovarian cancer
netdoctor.co.uk — “News - UK scientists trial new drug for hereditary breast and ovarian cancer” View full resource at netdoctor.co.uk
Most Recently Shared on August 18, 2011 at 10:03 pm By:
Komen for the Cure Health Organization
England scientists started a clinical trial w/ the drug 6MP in wmn w/ adv breast or ovarian cancer due to inherited genes http://ow.ly/66X7s
Many Doctors Ignore Cancer Genetic Testing Guidelines - Drugs.com MedNews
drugs.com — “Many doctors are not following guidelines on genetic counseling and testing for women at average and high risk for breast and ovarian cancer, according to a new” View full resource at drugs.com
Most Recently Shared on July 25, 2011 at 2:02 pm By:
Drugs and Devices OW OW Health
Many Doctors Ignore Cancer Genetic Testing Guidelines: MONDAY, July 25 -- Many doctors are not following g... http://bit.ly/pqwX1r #drug
Test boosts ovarian cancer treatment hopes | News | Nursing Times
nursingtimes.net — “Ovarian cancer patients will be able to take a test to determine whether they will benefit from a new type of drug.” View full resource at nursingtimes.net
Most Recently Shared on November 8, 2010 at 1:02 pm By:
News: Test boosts ovarian cancer treatment hopes http://bit.ly/c3PWBY
Dream Team targets molecular factors common in women's cancers - icyou health videos
icyou.com — “First clinical trials begin soon to test new drugs against ovarian, endometrial and breast cancers that harbor dysfunctional PI3K pathways. ...” View full resource at icyou.com
Most Recently Shared on September 17, 2010 at 6:23 pm By:
Tori Joseph - icyou.com Health Site
Dream Team targets molecular factors common in women's cancers http://bit.ly/bjctEb @MDAndersonNews
YouTube - Dream Team targets molecular factors common in women's cancers
youtube.com — “First clinical trials begin soon to test new drugs against ovarian, endometrial and breast cancers that harbor dysfunctional PI3K pathways. MD Anderson's Gor...” View full resource at youtube.com
Most Recently Shared on September 13, 2010 at 10:24 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
Dream Team targets molecular factors common in women's cancers: http://tinyurl.com/36867pn
New Drug Reduces Tumor Size In Women With Advanced Hereditary Ovarian Or Breast Cancer - QualityPoint Technologies
qualitypointtech.net — “Weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations. The Phase II ovarian cancer study results as well as another Phase II trial in which Cedars-Sinai researchers also participated that evaluated the drug's effectiveness in ” View full resource at qualitypointtech.net
Most Recently Shared on August 13, 2010 at 12:12 pm By:
New Drug Reduces Tumor Size In Women With Advanced Hereditary Ovarian Or Breast Cancer: Weakness of certain types ... http://bit.ly/aIfhJM
New drug shows promise against ovarian and breast cancer .:. newkerala.com Online News - United States 19907
newkerala.com — “New drug shows promise against ovarian and breast cancer - London, Aug 13 : An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.” View full resource at newkerala.com
Most Recently Shared on August 13, 2010 at 10:50 am By:
New drug shows promise against ovarian and breast cancer: London, Aug 13 : An international consortium of research... http://bit.ly/aqmNbY
New Drug Reduces Tumor Size in Women with Advanced Hereditary Ovarian Or Breast Cancer
newswise.com — “Understanding the underlying genetic weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.” View full resource at newswise.com
Most Recently Shared on August 12, 2010 at 4:51 pm By:
New Drug Reduces Tumor Size in Women with Advanced Hereditary Ovarian Or Breast Cancer: Understanding the underlyi... http://bit.ly/aCQfwr
New Drug Reduces Tumor Size in Women with Advanced Hereditary Ovarian Or Breast Cancer
newswise.com — “Understanding the underlying genetic weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.” View full resource at newswise.com
Most Recently Shared on August 12, 2010 at 2:27 pm By:
newswise Health Communicator and Health News
New Drug Reduces Tumor Size in Women with Advanced Hereditary Ovarian Or Breast Cancer: Understanding the underlyi... http://bit.ly/9GcFrv
New drug reduces tumor size in women with advanced hereditary ovarian or breast cancer
physorg.com — “Understanding the underlying genetic weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women ...” View full resource at physorg.com
Most Recently Shared on August 12, 2010 at 2:10 pm By:
PhysOrg Health News Health News
New drug reduces tumor size in women with advanced hereditary ovarian or breast cancer http://tw.physorg.com/200825528
Olaparib -- A Novel Drug To Treat Hereditary Breast & Ovarian Cancer Video
vodpod.com — “Dr Andrew Tutt, Consultant Clinical Oncologist and Director of the Breakthrough Breast Cancer Research Unit at King's College London, discussing olaparib, the first of a totally new type of cancer treatments that is showing promise for patients with inherited forms of breast and ovarian cancer. 06 Jul 10.” View full resource at vodpod.com
Most Recently Shared on July 6, 2010 at 3:53 pm By:
Paul Cacciatore Patient Advocate
Dr Andrew Tutt, Consultant Clinical Oncologist and Director of the Breakthrough Breast Cancer Research Unit at King's … http://bit.ly/9EuSOn
New Drug Aims To 'Seek And Destroy' Many Types Of Cancer
sciencedaily.com — “A new drug designed to "seek and destroy" common cancers is being tested. The Phase I clinical trial is designed to evaluate the safety of EP-100 in adult patients with solid tumors whose tumor biopsies indicate that they have excessive LHRH receptors. Excessive LHRH receptors are found in a wide range of cancers, including breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers.” View full resource at sciencedaily.com
Most Recently Shared on October 15, 2009 at 1:29 pm By:
Matthew Zachary Patient Expert
The opposite of congress is progress. Now, this sounds like progress. http://bit.ly/2eUQE5
New drug aims to 'seek and destroy' many types of cancer
physorg.com — “A new drug designed to 'seek and destroy' common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.” View full resource at physorg.com
Most Recently Shared on October 5, 2009 at 7:07 pm By:
New drug aims to 'seek and destroy' many types of cancer http://bit.ly/i0VPE
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
news-medical.net — “Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers.” View full resource at news-medical.net
Most Recently Shared on May 22, 2009 at 9:27 am By:
Ovarian Cancer News: Genetic testing for breast or ovarian cancer risk may be greatly underu.. http://buzzup.com/3yzj
Advertisement
PhysOrg Health News
@physorg_health
New drug reduces tumor size in women with advanced hereditary ovarian or breast cancer http://tw.physorg.com/200825528
1 year ago...